AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE

AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE was reported 41 times

AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CLAUDICATION OF JAW MUSCLES 2 0.0333
1 PRODUCT CONTAMINATION CHEMICAL 2 0.0092
2 BRONCHIAL NEOPLASM 1 0.0074
3 EAR NEOPLASM 2 0.0073
4 SUBGALEAL HAEMATOMA 1 0.0060
5 BRONCHIAL HAEMORRHAGE 1 0.0032
6 ENDOMETRIAL ABLATION 1 0.0028
7 NASAL TURBINATE HYPERTROPHY 1 0.0027
8 NEOPLASM SKIN 2 0.0013
9 INTERMITTENT CLAUDICATION 2 0.0013
10 HYPOREFLEXIA 2 0.0010
11 RHONCHI 1 0.0007
12 INFECTIOUS PLEURAL EFFUSION 1 0.0007
13 BRONCHIAL DISORDER 1 0.0006
14 ANTIBODY TEST POSITIVE 1 0.0006
15 RECALLED PRODUCT 1 0.0006
16 DRUG WITHDRAWAL CONVULSIONS 1 0.0006
17 IMMUNE-MEDIATED MYOSITIS 1 0.0004
18 TUMOUR HAEMORRHAGE 1 0.0004
19 GRANULOMA 1 0.0003
20 MYASTHENIA GRAVIS 2 0.0002
21 NAIL DISORDER 2 0.0002
22 BREATH SOUNDS ABNORMAL 1 0.0002
23 EYELID PTOSIS 2 0.0002
24 LOW DENSITY LIPOPROTEIN INCREASED 1 0.0001
25 BASAL CELL CARCINOMA 2 0.0001
26 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
27 AFFECTIVE DISORDER 1 0.0001
28 RHINITIS 1 0.0001
29 CARDIAC MURMUR 1 0.0001
30 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
31 RECALLED PRODUCT ADMINISTERED 1 0.0001
32 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
33 BODY HEIGHT DECREASED 1 0.0001
34 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
35 NEPHROPATHY TOXIC 1 0.0001
36 SPINAL PAIN 1 0.0001
37 PHARYNGITIS 1 0.0001
38 EYE HAEMORRHAGE 1 0.0001
39 MALIGNANT MELANOMA 1 0.0001
40 SINUS TACHYCARDIA 1 0.0001
41 ANKLE FRACTURE 1 0.0001
42 GALLBLADDER DISORDER 1 0.0001
43 SKIN FISSURES 1 0.0001
44 KIDNEY INFECTION 1 0.0001
45 UPPER LIMB FRACTURE 1 0.0001
46 PRODUCT PRESCRIBING ERROR 1 0.0000
47 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
48 DEAFNESS 1 0.0000
49 GASTRITIS 1 0.0000
50 DYSPHONIA 2 0.0000
51 RESPIRATORY DISORDER 1 0.0000
52 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
53 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
54 BRONCHITIS 2 0.0000
55 THROMBOSIS 2 0.0000
56 BLINDNESS 1 0.0000
57 LUNG NEOPLASM MALIGNANT 1 0.0000
58 OSTEOPOROSIS 1 0.0000
59 COMPLETED SUICIDE 2 0.0000
60 LOWER RESPIRATORY TRACT INFECTION 1 0.0000
61 HYPOKALAEMIA 1 0.0000
62 BLOOD CHOLESTEROL INCREASED 1 0.0000
63 OCULAR HYPERAEMIA 1 0.0000
64 DRY EYE 1 0.0000
65 ILLNESS 2 0.0000
66 OEDEMA 1 0.0000
67 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
68 INFLUENZA 2 0.0000
69 OXYGEN SATURATION DECREASED 1 0.0000
70 HERPES ZOSTER 1 0.0000
71 NASAL CONGESTION 1 0.0000
72 WHEEZING 1 0.0000
73 CATARACT 1 0.0000
74 VERTIGO 1 0.0000
75 EXPOSURE DURING PREGNANCY 1 0.0000
76 RENAL FAILURE 2 0.0000
77 INJECTION SITE REACTION 1 0.0000
78 BURNING SENSATION 1 0.0000
79 EPISTAXIS 1 0.0000
80 INJECTION SITE SWELLING 1 0.0000
81 DRUG INTERACTION 2 0.0000
82 INFLUENZA LIKE ILLNESS 1 0.0000
83 SKIN EXFOLIATION 1 0.0000
84 BALANCE DISORDER 1 0.0000
85 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
86 GASTROINTESTINAL DISORDER 1 0.0000
87 ADVERSE DRUG REACTION 1 0.0000
88 NASOPHARYNGITIS 2 0.0000
89 SYNCOPE 1 0.0000
90 CHEST DISCOMFORT 1 0.0000
91 SINUSITIS 1 0.0000
92 HYPERTENSION 2 0.0000
93 ASTHMA 1 0.0000
94 DEPRESSION 2 0.0000
95 JOINT SWELLING 1 0.0000
96 OEDEMA PERIPHERAL 1 0.0000
97 VISUAL IMPAIRMENT 1 0.0000
98 DRY SKIN 1 0.0000
99 MEMORY IMPAIRMENT 1 0.0000
100 INFECTION 1 0.0000
101 CONDITION AGGRAVATED 2 0.0000
102 BLOOD PRESSURE INCREASED 1 0.0000
103 PERIPHERAL SWELLING 1 0.0000
104 PNEUMONIA 2 0.0000
105 FALL 2 0.0000
106 URINARY TRACT INFECTION 1 0.0000
107 HYPERSENSITIVITY 1 0.0000
108 PRODUCT USE ISSUE 1 0.0000
109 BLOOD GLUCOSE INCREASED 1 0.0000
110 GAIT DISTURBANCE 1 0.0000
111 ALOPECIA 1 0.0000
112 HYPOTENSION 1 0.0000
113 SOMNOLENCE 1 0.0000
114 RASH 2 0.0000
115 WEIGHT INCREASED 1 0.0000
116 FEELING ABNORMAL 1 0.0000
117 COUGH 1 0.0000
118 PRODUCT DOSE OMISSION ISSUE 1 0.0000
119 INJECTION SITE PAIN 1 0.0000
120 HEADACHE 2 0.0000
121 PRURITUS 1 0.0000
122 DEATH 2 0.0000
123 MALAISE 1 0.0000
124 DYSPNOEA 1 0.0000
125 PAIN 1 0.0000
126 DRUG INEFFECTIVE 2 0.0000
127 FATIGUE 1 0.0000